Key Events This Week
1 June: MarketsMOJO upgrades Gland Pharma to Buy on strong technical and financial performance
1 June: Technical momentum shifts signal bullish outlook amid volatility
5 June: Stock closes the week at Rs.2,272.15, up 1.00% for the week

Gland Pharma Ltd is Rated Buy
2026-06-12 10:10:41Gland Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2395
2026-06-11 13:13:30Surging to a fresh 52-week high of Rs 2395 on 11 Jun 2026, Gland Pharma Ltd has demonstrated robust price momentum, outpacing its sector and the broader market with a 5.31% gain on the day. This milestone caps a remarkable 42.47% rally over the past year, significantly outperforming the Sensex’s 10.03% decline during the same period.
Read full news article
Gland Pharma Ltd Upgraded to Buy by MarketsMOJO on Strong Technical and Financial Performance
2026-06-01 08:26:36Gland Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The company’s robust quarterly financial results, improved technical outlook, and sustained market-beating returns have collectively driven this positive revision in investment stance.
Read full news article
Gland Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Volatility
2026-06-01 08:04:42Gland Pharma Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an upgrade from mildly bullish to bullish territory. Despite a recent dip in price, the pharmaceutical small-cap’s technical parameters suggest strengthening momentum, supported by mixed but predominantly positive signals from MACD, moving averages, and Bollinger Bands. This evolving technical landscape offers investors a nuanced perspective on the stock’s near-term trajectory amid broader market volatility.
Read full news articleGland Pharma Ltd Falls 3.41%: Key Technical Signals Shape Weekly Trend
2026-05-30 11:05:18
Key Events This Week
May 25: New 52-week high at Rs.2,391.25
May 29: Formation of Golden Cross, signalling potential bullish breakout
Week Close: Rs.2,249.75 (-3.41%) vs Sensex +0.01%

Golden Cross Confirmed: Do Gland Pharma Ltd's Other Technical Indicators Agree?
2026-05-29 18:00:46The 50-day moving average has crossed above the 200-day moving average for Gland Pharma Ltd, signalling a golden cross on 29 May 2026. Yet, the stock declined 2.75% on the day the cross formed, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals invites a closer examination of the technical and fundamental context surrounding the event.
Read full news article
Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2391.25
2026-05-25 10:50:05With a 53.45% gain over the past year, Gland Pharma Ltd has surged past its previous 52-week high to touch Rs 2391.25 on 25 May 2026, significantly outperforming the Sensex which declined 6.56% over the same period.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
19-Jun-2026 | Source : BSECopy of Newspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
18-Jun-2026 | Source : BSENotice of the Postal Ballot
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17-Jun-2026 | Source : BSESchedule of Investor Meet
Corporate Actions
No Upcoming Board Meetings
Gland Pharma Ltd has declared 1800% dividend, ex-date: 14 Aug 25
No Splits history available
No Bonus history available
No Rights history available







